1Radboud University Medical Center, Nijmegen, The Netherlands
2University of British Columbia, Vancouver, BC, Canada
3National Institutes of Health, Bethesda, MD, USA
4University of Birmingham, Birmingham, UK
5New York Academy of Medicine, New York City, NY, USA
6City College, New York City, NY, USA
Countries around the world are experiencing an ever-increasing need to make choices in investments in health and healthcare. This makes it incumbent upon them to have formal processes in place to optimize the legitimacy of eventual decisions. There is now growing experience among countries of the implementation of stakeholder participation, and a developing convergence of methods to support decision-makers within health authorities in making tough decisions when faced with the stark reality of limited resources. We call for further interaction among health authorities, and the research community to develop best practices in order to confront the difficult choices that need to be made.
Chhatwal J, Kanwal F, Roberts MS, Dunn MA. Cost-effectiveness and budget impact of hepatitis C virus treatment with sofosbuvir and ledipasvir in the United States. Ann Intern Med. 2015;162(6):397-406. doi:10.7326/M14-1336
Ottersen T, Norheim OF, Chitah BM, et al. Making fair choices on the path to universal health coverage. Bull World Health Organiz. 2014;92(6):389.
Daniels N, Charvel S, Gelpi AH, Porteny T, Urrutia J. Role of the courts in the progressive realization of the right to health: between the threat and the promise of judicialization in Mexico. Health Sys Ref. 2015;1(3):229-234.
Williams I. Institutions, cost-effectiveness analysis and healthcare rationing: the example of healthcare coverage in the English National Health Service. Policy Polit. 2013;41(2):223-239.
International Decision Support Initiative (iDSI) website. http://www.idsihealth.org/. Accessed September 16, 2016.
European Network on Health Technology Assessment (EUnetHTA) website. http://www.eunethta.net/. Accessed September 16, 2016.
Baltussen R, Jansen MP, Mikkelsen E, et al. Priority setting for universal health coverage: we need evidence-informed deliberative processes, not just more evidence on cost-effectiveness. Int J Health Policy Manag. 2016;5(11):615-618. doi:10.15171/ijhpm.2016.83
Daniels N. Accountability for reasonableness. BMJ. 2000;321(7272):1300-1301.
Baroe K, Baltussen R. Legitimate healthcare limit setting in a real-world setting: integrating accountability for reasonableness and multi-criteria decision analysis. Public Health Ethics. 2014;7(2):98-111. doi:10.1093/phe/phu006
Gibson J, Mitton C, Martin D, Donaldson C, Singer P. Ethics and economics: does programme budgeting and marginal analysis contribute to fair priority setting? J Health Serv Res Policy. 2006;11(1):32-37. doi:10.1258/135581906775094280